Piperacillin/Tazobactam Kabi Pulver til infusionsvæske, opløsning 4g/0,5g

Piperacillin/Tazobactam Kabi is an intravenous antibiotic combination containing the extended-spectrum penicillin piperacillin and the beta-lactamase inhibitor tazobactam. This combination broadens the spectrum of piperacillin by making it effective against organisms that express beta-lactamase, which would normally degrade piperacillin. The product is primarily manufactured in Germany, where Fresenius Kabi is headquartered, but it is also produced in other locations to meet global demand. Fresenius Kabi, the company behind this product, is a global healthcare company specializing in life-saving medicines and technologies, particularly in the fields of infusion therapy, clinical nutrition, and medical devices. The company is headquartered in Germany and operates worldwide, providing a range of products and services to healthcare providers and patients.